Literature DB >> 2513036

Gall stones and treatment with octreotide for acromegaly.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2513036      PMCID： PMC1838019          DOI： 10.1136/bmj.299.6708.1162-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Changes in glucose tolerance and development of gall stones during high dose treatment with octreotide for acromegaly.

Authors:  J A McKnight; D R McCance; J G Crothers; A B Atkinson
Journal:  BMJ       Date:  1989-09-02

2.  Sensitivity and specificity of microscopic examination of gallbladder bile for gallstone recognition and identification.

Authors:  M J Ramond; M Dumont; J Belghiti; S Erlinger
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

3.  Utility of biliary microscopy for the prediction of the chemical composition of gallstones and the outcome of dissolution therapy with ursodeoxycholic acid.

Authors:  E Ros; S Navarro; I Fernández; M Reixach; J M Ribó; J Rodés
Journal:  Gastroenterology       Date:  1986-09       Impact factor: 22.682

4.  Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men.

Authors:  B Lembcke; W Creutzfeldt; S Schleser; R Ebert; C Shaw; I Koop
Journal:  Digestion       Date:  1987       Impact factor: 3.216

5.  Cholesterol crystals and the formation of cholesterol gallstones.

Authors:  A Sedaghat; S M Grundy
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245
  5 in total
  1 in total

Review 1.  Drug-induced gallbladder disease. Incidence, aetiology and management.

Authors:  P P Michielsen; H Fierens; Y M Van Maercke
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.